In addition, due to the expression of Trop-2 in tissues such as the skin, upper digestive tract mucosa, and ocular surface conjunctival epithelium, ocular toxicity and oral mucositis are non-tumor targeted toxicities that need to be closely monitored during the application. This evidence concerns the gene TACSTD2 and neoplasm.